Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Management of Hypotension in the Preterm
2010-023988-17Phase 3Terminated
- Sponsor
- BrePco Biopharma
- Start
- Jan 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of dopamine in hypotension (2 arms), sponsored by BrePco Biopharma. Primary endpoint: Survival free from neurodisability at 2 years corrected gestational age. Started Jan 2013; status: terminated.
02
Drugs
dopamine
03
Conditions
hypotension
Beyond the preview
Go deeper on 2010-023988-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-023988-17.